Prabuddha Mukherjee,1 Aneesh Alex,2,3 Edita Aksamitiene,1 Derek Shi,1 Darold R. Spillman Jr.https://orcid.org/0000-0001-9946-2659,3 Marina Marjanovic,1 Michael Fazio,4 Punit Seth,4 Kendal Frazier,2 Steve R. Hood,2,3 Stephen A. Boppart3
1Univ. of Illinois (United States) 2GlaxoSmithKline (United States) 3Univ. of Illinois (United States) 4Ionis Pharmaceuticals, Inc. (United States)
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Antisense oligonucleotides (ASOs) are single stranded negatively charged molecules which downregulate the translation of specific target messenger RNA (mRNA). Chemically modified ASOs with phosphorothioate (PS) linkages have been extensively studied as research tools and as clinical therapeutics and nine oligonucleotide-based drugs have been approved by regulatory agencies. While several cell surface proteins that bind PS-ASOs and mediate their cellular uptake have been identified, the mechanisms leading to productive internalization of PS-ASOs are not well understood. We demonstrate the potential of hyperspectral CARS imaging to detect the intracellular presence of ASOs in a label-free manner.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Prabuddha Mukherjee, Aneesh Alex, Edita Aksamitiene, Derek Shi, Darold R. Spillman Jr., Marina Marjanovic, Michael Fazio, Punit Seth, Kendal Frazier, Steve R. Hood, Stephen A. Boppart, "Label-Free detection of antisense oligonucleotide uptake in Murine cells using hyperspectral CARS imaging," Proc. SPIE 11656, Advanced Chemical Microscopy for Life Science and Translational Medicine 2021, 116561F (5 March 2021); https://doi.org/10.1117/12.2578061